Aisling Capital Management as of Dec. 31, 2019
Portfolio Holdings for Aisling Capital Management
Aisling Capital Management holds 13 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bridgebio Pharma (BBIO) | 51.5 | $134M | 3.8M | 35.05 | |
| Eidos Therapeutics | 24.7 | $65M | 1.1M | 57.39 | |
| Avrobio Ord (AVRO) | 6.9 | $18M | 893k | 20.13 | |
| Aeglea Biotherapeutics | 3.8 | $9.9M | 1.3M | 7.64 | |
| Atreca Inc Cl A (BCEL) | 2.3 | $6.0M | 388k | 15.47 | |
| Marker Therapeutics Ord | 2.2 | $5.8M | 2.0M | 2.88 | |
| Obseva Sa | 2.0 | $5.3M | 1.4M | 3.82 | |
| Zosano Pharma Corp | 1.6 | $4.1M | 2.7M | 1.52 | |
| Sunesis Pharmaceuticals Inc Ne | 1.3 | $3.4M | 10M | 0.34 | |
| Arcus Biosciences Incorporated (RCUS) | 1.3 | $3.4M | 333k | 10.10 | |
| Verona Pharma Plc ads (VRNA) | 1.0 | $2.6M | 444k | 5.75 | |
| Nabriva Therapeutics | 1.0 | $2.5M | 1.9M | 1.32 | |
| Aclaris Therapeutics (ACRS) | 0.5 | $1.2M | 635k | 1.89 |
